NEJM Journal Watch
  • Renew
  • Subscribe
  • My Account
    • My Alerts
    • Activate Online
    • Subscribe
    • Renew
  • SPECIALTIES & TOPICS
    Specialties:
    • Cardiology
    • Emergency Medicine
    • Gastroenterology
    • General Medicine
    • HIV/AIDS Clinical Care
    • Hospital Medicine
    • Infectious Diseases
    • Neurology
    • Oncology and Hematology
    • Pediatrics and Adolescent Medicine
    • Psychiatry
    • Women's Health
    Topics:
    • Aging/Geriatrics
    • Allergy/Asthma
    • Arthritis/Rheumatic Disease
    • Breast Cancer
    • Coronavirus (COVID-19)
    • Diabetes
    • Hypertension
    • Lipid Management
    • Nutrition/Obesity
    • Respiratory Infections
    • STDs
    • Stroke
  • NEWS
  • BLOGS
    • HIV and ID Observations
    • Insights on Residency Training
    • Clinical Conversations
  • CME
  • SPECIAL FEATURES
    • Coronavirus (COVID-19)
    • Clinical Spotlight
    • Guideline Watch
  • ARCHIVE/PDFs
RSS

CardioExchange Archive

CardioExchange, an NEJM practice community for medical professionals dedicated to improving cardiac patient care, was active from 2009 to 2015. CardioExchange fostered discussion between clinicians from across the globe.

March 28th, 2014

ACC.14 Headquarters

wpengine

CardioExchange is dedicated to bringing you the latest from ACC.14. Check out our coverage of the conference ─ and some of the great debates these posts have sparked ─ then tell us what you think!

News:

  • No Benefit Found in First Real Test of Renal Denervation
  • Survival Advantage for TAVR Over Surgery in High-Risk Patients
  • First TAVR Comparison Trial Favors Sapien XT Over CoreValve
  • MADIT-CRT Long-Term Follow-Up Shows Survival Benefit with CRT-D
  • High-Sensitivity Troponin Test Could Identify Low-Risk Chest Pain Patients in the ED
  • Aspirin and Clonidine Fail to Help Surgery Patients
  • Novartis Trial Was Stopped Early Because of a Significant Drop in Cardiovascular Mortality

Analysis:

  • Negative Findings on Renal Denervation for Hypertension: Sweet SYMPLICITY?
  • TAVR: Are You Impressed Now?
  • Long-Term Follow-Up from MADIT-CRT: Guideline Implications
  • Are We Equipped to Make a CHOICE Between TAVR Devices?

Follow our Fellows:

  • Changing My Priorities for ACC.14
  • Ideals Lost, But Not Stolen
  • Are Digital Conferences the Way of the Future?
  • Taking Patient-Centerdness to the Next Level at ACC.14
  • Stage Set for Phase IV Trials of PCSK9 Inhibition
  • Master of all Trades

Categories: General


You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

Comments are closed.

    • Search
    • Archives
  • RSS NEJM Journal Watch — Recent Cardiology Articles

    • Can Multimodality Plaque Imaging Identify Vulnerable Plaques and Patients?
    • Assessing Health Status in Heart Failure: A Better Way
    • COVID-19 Coverage This Week in NEJM Journal Watch
    • Blood Pressure and Cardiovascular Risk: Another Way to Assess the Connection
    • Preventing Heart Disease in Women: New Guidance from the American Heart Association
  • Sign up for NEJM Journal Watch Cardiology Alerts

    Receive a free weekly email with the latest summaries on Cardiology.

    SIGN UP
  • Physician's First Watch
    Today's breaking medical news
    Read more news
  • Tag Cloud

    • ACS AF AHA American Heart Association anticoagulation aortic valve replacement apixaban aspirin atrial fibrillation CABG cardiovascular risk cholesterol clopidogrel dabigatran diabetes diet drug-eluting stents epidemiology ESC exercise FDA Fellowship training guidelines HDL heart failure hypertension ICDs MI myocardial infarction obesity PCI Primary PCI risk factors rivaroxaban statins STEMI stents stroke stroke prevention TAVI TAVR type 2 diabetes venous thromboembolism warfarin women
  • Help & FAQs
  • Terms of Use
  • Privacy Policy
  • Cookie Information
  • Copyright Information
  • NEJM Group
  • NEJM Knowledge+
  • NEJM Catalyst
  • NEJM Resident 360
  • About NEJM Journal Watch
  • Product Information
  • Specialties & Topics
  • Advertisers
  • Institutions
  • Editorial Policies
  • Archive of PDF Issues
  • RSS
  • Activate Print Subscription
  • Subscribe
  • Renew
  • Create Account
  • Sign Up for Email Alerts
  • Pay A Bill
  • Contact Us
Follow Us:
  • Facebook
  • Twitter
  • Feeds

NEJM Journal Watch is a publication of NEJM Group,
a division of the Massachusetts Medical Society.

NEJM Group

Copyright © 2021 Massachusetts Medical Society.
All rights reserved.